BPS3012 Chap.7 Targeted Protein Degradation
Targeted Protein Degradation
Targeted Protein Degradation uses the ubiquitin-proteasome system to remove a selected protein. The chapter explains event-driven pharmacology, PROTAC architecture, productive ternary-complex geometry, ubiquitination and proteasomal processing.
It also evaluates degradation depth, kinetics, selectivity and the hook effect.
A bifunctional degrader contains a ligand for the protein of interest, a linker and a ligand that recruits an E3 ubiquitin ligase. The molecule must form a productive ternary complex, position the target for ubiquitination and allow the tagged protein to be processed by the proteasome. Binding is therefore necessary but not sufficient.
Geometry, cooperativity, cellular access, ligase availability and the target’s own biology can determine whether a strong binder becomes an effective degrader.
Degradation is event-driven rather than sustained occupancy-driven. After promoting a productive event, a degrader may dissociate and participate again.
This creates the possibility of deep or durable protein loss at concentrations that do not require continuous target occupancy. It does not mean every degrader is automatically more potent or selective than an inhibitor. Measure the concentration producing degradation, the maximum depth, the time course and recovery.
Those properties answer different questions and should not be collapsed into one potency number.
The hook effect shows why more compound is not always better. At high concentration, separate binary complexes with target or ligase can become more common than the productive ternary complex, reducing degradation. Selectivity can also emerge from ternary-complex geometry even when the target ligand binds related proteins.
Conversely, an apparently selective biochemical design can produce unexpected cellular loss.
Proteomic measurement, mechanistic controls and time-resolved experiments help distinguish intended degradation from indirect change.
For assessment answers, trace the complete chain: degrader enters the cell, recruits target and ligase, forms a productive complex, promotes ubiquitination, releases, and leaves the proteasome to remove the target.
Then evaluate delivery, molecular size, tissue exposure, ligase distribution, resistance and safety. Compare a degrader with an inhibitor using biological objective, occupancy requirement, catalytic potential, selectivity, pharmacokinetics and evidence. End with the experiment that would distinguish genuine event-driven degradation from reduced expression or nonspecific toxicity.
What this chapter covers
- 01
Ubiquitin-proteasome system
- 02
E3 ligase and substrate specificity
- 03
Event-driven versus occupancy-driven action
- 04
Target binder, linker and E3 binder
- 05
Productive ternary-complex geometry
- 06
Ubiquitination, degradation and recovery
- 07
Selectivity, hook effect and therapeutic window
Worked example · free
Diagnose binding without degradation
- +1Confirm ternary-complex formation and cooperativity.
- +1Assess linker length, attachment points and complex geometry.
- +1Measure cellular permeability and intracellular concentration.
- +1Test ubiquitin transfer and accessible target lysines.
- +1Show dependence on the recruited ligase and proteasome.
- +1Connect target loss to the downstream phenotype.
Key terms
- Ubiquitin
- A small protein tag that can mark a target for recognition and processing by the proteasome.
- E3 ligase
- A component of the ubiquitination machinery that contributes substrate specificity.
- PROTAC
- A bifunctional molecule linking a target-binding ligand to an E3-ligase ligand.
- Ternary complex
- The assembly of target, degrader and E3 ligase required for productive recruitment.
- Hook effect
- Reduced ternary-complex formation and degradation at high degrader concentrations when separate binary complexes dominate.
Targeted Protein Degradation FAQ
How does a PROTAC differ from an inhibitor?
An inhibitor usually relies on continued target occupancy, while a PROTAC recruits degradation machinery to trigger removal of the protein. That event can persist after the degrader disengages. This event-driven logic can produce durable loss, but it does not guarantee superiority. Cellular entry, ternary-complex geometry, ligase availability, ubiquitination and proteasomal processing must all succeed.
Compare depth, kinetics and recovery as well as binding, and distinguish true target loss from reduced expression or nonspecific toxicity.
Why does linker design matter?
The linker helps determine whether target and ligase form a productive geometry. Strong binding to both partners can still fail if ubiquitin cannot be transferred efficiently. Linker changes can alter cooperativity, selectivity, permeability and the position of accessible lysines. This is why binary affinity cannot predict degradation alone.
Test formation of the productive complex and follow target abundance over concentration and time, including high concentrations where separate binary complexes may create a hook effect.
Does deep target loss prove therapeutic value?
No. Target loss must occur in the relevant tissue, produce a disease-linked functional effect and spare enough normal function to create a therapeutic window. Depth of degradation in a convenient cell line does not establish exposure, selectivity or benefit in the intended tissue. Follow the evidence from productive ternary complex through protein loss, pathway response and phenotype, and include recovery over time.
Proteomic and mechanistic controls help distinguish intended removal from indirect change or toxicity.
Assessment move
Reproduce the degradation chain from ternary complex to ubiquitination, proteasome and phenotype. For failure questions, locate the first unsupported hand-off. Compare binding potency, degradation potency, maximum depth, time course and recovery without treating them as interchangeable.
